Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation

Trends in Cell Biology

Volumn 12, Issue 6, 2002, Pages 258-266

  Stork, Philip J S ^a   Schmitt, John M ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; GUANOSINE TRIPHOSPHATASE; ISOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN TYROSINE KINASE; RAF PROTEIN; RAP PROTEIN; RAS PROTEIN;

CELL CYCLE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELL SPECIFICITY; CELL STIMULATION; CELL TYPE; ENZYME ACTIVATION; ENZYME INHIBITION; GROWTH INHIBITION; HORMONAL REGULATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CELL DIFFERENTIATION; CELL DIVISION; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; PROTO-ONCOGENE PROTEINS PP60(C-SRC); RAP1 GTP-BINDING PROTEINS; RECEPTOR CROSS-TALK; SIGNAL TRANSDUCTION;

EID: 0036607064     PISSN: 09628924     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0962-8924(02)02294-8     Document Type: Review

References (125)

1. The role of cAMP in regulating tumour cell growth
2. New signaling pathways for hormones and cyclic adenosine 3′,5′-monophosphate action in endocrine cells
3. CAMP-mediated growth inhibition in fibroblasts is not mediated via mitogen-activated protein (MAP) kinase (ERK) inhibition. cAMP-dependent protein kinase induces a temporal shift in growth factor-stimulated MAP kinases
4. Coordinate, biphasic activation of p44 mitogen-activated protein kinase and S6 kinase by growth factors in hamster fibroblasts. Evidence for thrombin-induced signals different from phosphoinositide turnover and adenylylcyclase inhibition
5. CAMP inhibits linoleic acid-induced growth by antagonizing p27(kip1) depletion, but not interfering with the extracellular signal-regulated kinase or AP-1 activities
6. Embryonic lethality and fetal liver apoptosis in mice lacking the c-raf-1 gene
7. Differential regulation of extracellular signal-regulated protein kinases (ERKs) 1 and 2 by cAMP and dissociation of ERK inhibition from anti-mitogenic effects in rabbit vascular smooth muscle cells
8. Stimulatory and inhibitory effects of adenosine A(2A) receptors on nerve growth factor-induced phosphorylation of extracellular regulated kinases 1/2 in PC12 cells
9. C-jun N-terminal kinase but not mitogen-activated protein kinase is sensitive to cAMP inhibition in lymphocytes
10. Induction of p21WAF1 expression via Sp1-binding sites by tamoxifen in estrogen receptor-negative lung cancer cells
11. Protein kinase A regulates expression of p27(kip1) and cyclin D3 to suppress proliferation of leukemic T cell lines
12. Cyclin D1 expression is a major target of the cAMP-induced inhibition of cell cycle entry in fibroblasts
13. CAMP-mediated growth inhibition of lymphoid cells in G1: Rapid down-regulation of cyclin D3 at the level of translation
14. Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase 4 activation
15. Paradoxical accumulation of the cyclin-dependent kinase inhibitor p27kip1 during the cAMP-dependent mitogenic stimulation of thyroid epithelial cells
16. New functional activities for the p21 family of CDK inhibitors
17. The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts
18. Analysis of the Gs/mitogen-activated protein kinase pathway in mutant S49 cells
19. Up-regulation of the cAMP/PKA pathway inhibits proliferation, induces differentiation, and leads to apoptosis in malignant gliomas
20. CAMP protection of pancreatic cancer cells against apoptosis induced by ERK inhibition
21. Activation of the cAMP signaling pathway increases apoptosis in human B-precursor cells and is associated with downregulation of Mcl-1 expression
22. Differentiation of PC12 cells in response to a cAMP analogue is accompanied by sustained activation of mitogen-activated protein kinase. Comparison with the effects of insulin, growth factors and phorbol esters
23. The localization and activity of cAMP-dependent protein kinase affect cell cycle progression in thyroid cells
24. Protein kinase A antagonizes platelet-derived growth factor-induced signaling by mitogen-activated protein kinase in human arterial smooth muscle cells
25. Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3′,5′-monophosphate
26. CAMP antagonizes p21ras-directed activation of extracellular signal-regulated kinase 2 and phosphorylation of mSos nucleotide exchange factor
27. Inhibition by cAMP of Ras-dependent activation of Raf
28. Increasing cAMP attenuates activation of mitogen-activated protein kinase
29. Negative regulation of Raf-1 by phosphorylation of serine 621
30. Regulation of Raf-1 activation and signalling by dephosphorylation
31. Phosphorylation and regulation of Raf by Akt (protein kinase B)
32. Dephosphorylation of Ser-259 regulates Raf-1 membrane association
33. Phosphorylation of serine 43 is not required for inhibition of C-Raf kinase by the cAMP-dependent protein kinase
34. A ras-related gene with transformation suppressor activity
35. RapV12 antagonizes Ras-dependent activation of ERK1 and ERK2 by LPA and EGF in Rat-1 fibroblasts
36. Cyclic AMP-dependent activation of Rap1b
37. Cyclic AMP-mediated inhibition of cell growth requires the small G protein rap1
38. Rap1 signalling: Adhering to new models
39. Cell type-specific regulation of B-Raf kinase by cAMP and 14-3-3 proteins
40. CAMP-dependent protein kinase induces cAMP-response element-binding protein phosphorylation via an intracellular calcium release/ERK-dependent pathway in striatal neurons
41. CAMP activates MAP kinase and Elk-1 through a B-Raf- and Rap1-dependent pathway
42. Differential effects of cAMP in neurons and astrocytes. Role of B-raf
43. 2-adrenergic receptor activates extracellular regulated kinases (ERKs) via the small G protein Rap1 and the serine/threonine kinase B-Raf
44. Rap1A is a substrate for cyclic AMP-dependent protein kinase in human neutrophils
45. On the mitogenic properties of Rab1b: CAMP-induced G1/S entry requires phosphorylation of Rap1b
46. PKA phosphorylation of Src mediates cAMP's inhibition of cell growth via Rap1
47. Rap1 mediates sustained MAP kinase activation induced by nerve growth factor
48. Ras and Rap1: Two highly related small GTPases with distinct function
49. Cyclic AMP inhibits extracellular signal-regulated kinase and phosphatidylinositol 3-kinase/Akt pathways by inhibiting Rap1
50. The GTPase Rap1 controls functional activation of macrophage integrin alphaMbeta2 by LPS and other inflammatory mediators
51. Rap1 is activated by erythropoietin or interleukin-3 and is involved in regulation of beta 1 integrin-mediated hematopoietic cell adhesion
52. Rap1A positively regulates T cells via integrin activation rather than inhibiting lymphocyte signaling
53. Requirement for C3G-dependent Rap1 activation for cell adhesion and embryogenesis
54. Rap1 GTPase-activating protein SPA-1 negatively regulates cell adhesion
55. The small GTPase, Rap1, mediates CD31-induced integrin adhesion
56. Rap1 functions as a key regulator of T-cell and antigen-presenting cell interactions and modulates T-cell responses
57. Distinct roles of the adaptor protein shc and focal adhesion kinase in integrin signaling to ERK
58. Regulation of anchorage-dependent signal transduction by protein kinase A and p21-activated kinase
59. Serine and tyrosine phosphorylations cooperate in Raf-1, but not B-Raf activation
60. S338 phosphorylation of Raf-1 is independent of phosphatidylinositol 3-kinase and Pak3
61. Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt
62. Coordinated regulation of Rap1 and thyroid differentiation by cyclic AMP and protein kinase A
63. Mechanism of protein kinase B activation by cyclic AMP-dependent protein kinase
64. Cyclic AMP inhibits Akt activity by blocking the membrane localization of PDK1
65. Serum- and glucocorticoid-inducible kinase SGK phosphorylates and negatively regulates B-Raf
66. Follicle-stimulating hormone (FSH) stimulates phosphorylation and activation of protein kinase B (PKB/Akt) and serum and glucocorticoid-induced kinase (Sgk): Evidence for A kinase-independent signaling by FSH in granulosa cells
67. A novel mitogen-activated protein kinase phosphatase: Structure, expression and regulation
68. Cyclic AMP-elevating agents induce the expression of MAP kinase phosphatase-1 in PC12 cells
69. Cyclic AMP inhibitors inhibits PDGF-stimulated mitogen-activated protein kinase activity in rat aortic smooth muscle cells via inactivation of c-Raf-1 kinase and induction of MAP kinase phosphatase-1
70. Activation of p59Fyn leads to melanocyte dedifferentiation by influencing MKP-1-regulated mitogen-activated protein kinase signaling
71. Differential signaling cascade of MAP kinase and S6 kinase depends on 3′,5′-monophosphate concentration in Schwann cells: Correlation to cellular differentiation and proliferation
72. Parathyroid hormone activates mitogen-activated protein kinase in opossum kidney cells
73. Coupling of cAMP/PKA and MAPK signaling in neuronal cells is dependent on developmental stage
74. Calcium and cAMP signals differentially regulate cAMP-responsive element-binding protein function via a Rap1-extracellular signal-regulated kinase pathway
75. Extracellular-signal-regulated kinase signalling in neurons
76. Some forms of cAMP-mediated long-lasting potentiation are associated with release of BDNF and nuclear translocation of phospho-MAP kinase
77. Interleukin-6- and cyclic AMP-mediated signaling potentiates neuroendocrine differentiation of LNCaP prostate tumor cells
78. Analysis of the role of the mitogen-activated protein kinase in mediating cyclic-adenosine 3′,5′-monophosphate effects on prolactin promoter activity
79. AP1 proteins mediate the cAMP response of the dopamine beta-hydroxylase gene
80. Parathyroid hormone activates mitogen-activated protein kinase via a cAMP-mediated pathway independent of Ras
81. Raf-1 and B-Raf proteins have similar regional distributions but differential subcellular localization in adult rat brain
82. Thyrotropin activates mitogen-activated protein kinase pathway in FRTL-5 by a cAMP-dependent protein kinase A-independent mechanism
83. Ras mediates the cAMP-dependent activation of extracellular signal-regulated kinases (ERKs) in melanocytes
84. Endothelial apoptosis in Braf-deficient mice
85. Elevation of cyclic adenosine 3′,5′-monophosphate potentiates activation of mitogen-activated protein kinase by growth factors in LNCaP prostate cancer cells
86. 14-3-3 proteins are required for maintenance of Raf-1 phosphorylation and kinase activity
87. The mouse B-raf gene encodes multiple protein isoforms with tissue-specific expression
88. Extracellular signal-regulated activation of Rap1 fails to interfere in Ras effector signalling
89. B-Raf dependent regulation of the MEK-1/MAP kinase pathway in PC12 cells and regulation by cAMP
90. Identification of the mechanisms regulating the differential activation of the MAPK cascade by epidermal growth factor and nerve growth factor in PC12 cells
91. Nerve growth factor-stimulated B-Raf catalytic activity is refractory to inhibition by cAMP-dependent protein kinase
92. The ERK-dependent signalling is stage-specifically modulated by FSH, during primary Sertoli cell maturation
93. Cyclic AMP-dependent activation of the proenkephalin gene requires phosphorylation of CREB at serine-133 and a Src-related kinase
94. 1-adrenergic Erk1/2 activation is Src- but not Gi-mediated in brown adipocytes
95. Activation of the small G protein Rap1 in dog thyroid cells by both cAMP-dependent and -independent pathways
96. PKA-independent activation of ERK and H,K-ATPase by cAMP in native kidney cells: role of Epac I
97. Quantitative determination of Rap 1 activation in cyclic nucleotide-treated HL-60 leukemic cells: Lack of Rap 1 activation in variant cells
98. Differential signaling of cyclic AMP. Opposing effects of exchange protein directly activated by cAMP and cAMP-dependent protein kinase A on protein kinase B activation
99. A family of cAMP-binding proteins that directly activate Rap1
100. Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP
101. CAMP cascade leads to Ras activation in cortical neurons
102. Requirement of Ras for the activation of mitogen-activated protein kinase by calcium influx, cAMP, and neurotrophin in hippocampal neurons
103. Cyclic AMP activates Ras
104. Ras signaling through PI3K confers hormone-independent proliferation that is compatible with differentiation
105. CAMP signaling selectively influences Ras effectors pathways
106. The guanine nucleotide exchange factor CNrasGEF activates ras in response to cAMP and cGMP
107. Ras-dependent activation of MAP kinase pathway mediated by G-protein beta gamma subunits
108. Switching of the coupling of the beta2-adrenergic receptor to different G proteins by protein kinase A
109. Dual effect of beta-adrenergic receptors on mitogen-activated protein kinase Evidence for a beta gamma-dependent activation and a G alpha s-cAMP-mediated inhibition
110. Crosstalk between cAMP-dependent kinase and MAP kinase through a protein tyrosine phosphatase
111. A novel regulatory mechanism of MAP kinases activation and nuclear translocation mediated by PKA and the PTP-SL tyrosine phosphatase
112. Rheb interacts with Raf-1 kinase and may function to integrate growth factor- and protein kinase A-dependent signals
113. CAMP-dependent protein kinase inhibits the mitogenic action of vascular endothelial growth factor and fibroblast growth factor in capillary endothelial cells by blocking Raf activation
114. Suppression of Ras-induced transformation of NIH 3T3 cells by activated G alpha s
115. A regulatory role for cAMP in phosphatidylinositol 3-kinase/p70 ribosomal S6 kinase-mediated DNA synthesis in platelet-derived-growth-factor-stimulated bovine airway smooth-muscle cells
116. Inhibition of platelet-derived growth factor-induced mitogenesis by phosphodiesterase 3 inhibitors: Role of protein kinase A in vascular smooth muscle cell mitogenesis
117. Effects of cAMP on ERK mitogen-activated protein kinase activity in hepatocytes do not parallel the bidirectional regulation of DNA synthesis
118. Pertussis toxin inhibits cholecystokinin- and epidermal growth factor-induced mitogen-activated protein kinase activation by disinhibition of the cAMP signaling pathway and inhibition of c-Raf-1
119. CAMP stimulates the in vitro proliferation of renal cyst epithelial cells by activating the extracellular signal-regulated kinase pathway
120. Both Gs and Gi proteins are critically involved in isoproterenol-induced cardiomyocyte hypertrophy
121. The ERK signaling cascade inhibits gonadotropin-stimulated steroidogenesis
122. Stimulation of lipolysis and hormone-sensitive lipase via the extracellular signal-regulated kinase pathway
123. Cyclic AMP stimulates the phosphorylation and activation of p42 and p44 mitogen-activated protein kinases in 3T3-F442A preadipocytes
124. Involvement of mitogen-activated protein kinase in cyclic adenosine 3′,5′-monophosphate-induced hormone gene expression in rat pituitary GH(3) cells
125. New signaling pathway for parathyroid hormone and cyclic AMP action on extracellular-regulated kinase and cell proliferation in bone cells: Checkpoint of modulation by cyclic AMP